Conference Coverage

A unique care model for comorbid depression, PTSD


 

FROM ASCP 2022

A model for other settings?

Commenting on the study, Nagy A. Youssef, MD, PhD, professor of psychiatry and director of clinical research at Ohio State University, Columbus, called the results “interesting.”

“Treating patients with comorbid mild to moderate depression and current or past PTSD within the primary care setting using a care management program could be a model for other VA hospitals as well as in non-VA settings,” said Dr. Youssef, who was not part of the study.

Dr. Youssef noted that not only was there no difference in symptomatic improvement between the depression-plus-PTSD and depression-only groups, but program completion rates did not differ.

This further emphasizes “the potential utility of this approach in initial patient treatment, especially with limited mental health resources and the need to help more patients,” he said.

Dr. Zuschlag and Dr. Youssef report no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Long COVID neuropsychiatric deficits greater than expected
MDedge Internal Medicine
Refugees have a high burden of chronic pain associated with mental illness
MDedge Internal Medicine
Intensive outpatient PTSD treatment linked to fewer emergency encounters
MDedge Internal Medicine
High rates of med student burnout during COVID
MDedge Internal Medicine
Novel drug ‘promising’ for concomitant depression, insomnia
MDedge Internal Medicine
Genetic testing for best antidepressant accurate, cost effective
MDedge Internal Medicine
Asian American teens have highest rate of suicidal ideation
MDedge Internal Medicine
Hormonal contraceptives protective against suicide?
MDedge Internal Medicine
Adjunctive psychotherapy may offer no benefit in severe depression
MDedge Internal Medicine
New onset-depression after RA diagnosis raises mortality risk ‘more than sixfold’
MDedge Internal Medicine